Vyant Bio Inc (VYNT) Inventory Turnover Ratio, from fourth quarter 2022 to fourth quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Vyant Bio Inc   (NASDAQ: VYNT)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Vyant Bio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Vyant Bio Inc 's inventory turnover ratio, the ratio that measures Vyant Bio Inc 's ability to manage its supply chain, sequentially decreased to 0.17 in the fourth quarter 2022, which does not come as a surprise, as the Vyant Bio Inc continue to experience headwinds, which also impact its supply chain. Vyant Bio Inc 's average inventory processing period in the Dec 31 2022 quarter, has increased to 2147 days, from 74 days, in the Sep 30 2022 quarter.

Within Healthcare sector 443 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 698 in the third quarter 2022, to 2063.

VYNT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vyant Bio Inc Market Share?

What is Inventory Turnover Ratio?




VYNT Inventory Turnover Ratio (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Inventory Growth -88.84 % -86.25 % 7.37 % 21.52 % -
Y / Y Cost of Sales Growth -99.66 % - - -57.3 % 80.45 %
Inventory Turnover Ratio (TTM) 0.17 - - 8.43 8.97
VYNT's Total Ranking # 2063 # 698 # 650 # 658 # 477
Average inventory processing period 2184 - - 43 41
Seq. Inventory Growth -19.7 % -84.9 % -12.07 % 4.63 % -1.04 %
Seq. Cost of Sales Growth - - - -97.87 % 65.98 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 444
Overall Market # 2063

Inventory Turnover Ratio Statistics
High Average Low
8.97 5.72 0.17
(Dec 31 2021)   (Dec 31 2022)




Financial Statements
Vyant Bio Inc 's Inventories $ 0 Millions Visit VYNT's Balance sheet
Vyant Bio Inc 's Cost of Revenues TTM $ 0 Millions Visit VYNT's Income Statement
What are VYNT's Sales? Visit VYNT's Sales by Segment

Other Inventory Turnover Ratios
Vyant Bio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VYNT's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VYNT's Competitors
Inventory Turnover Ratio for VYNT's Suppliers
Inventory Turnover Ratio for VYNT's Customers

You may also want to know
VYNT's Sales Growth Rates VYNT's Pe Price to earnings ratio VYNT's Receivables Turnover Ratio VYNT's Stock Quote
VYNT's Net Income Growth Rates VYNT's Ps Price to Sales ratio VYNT's Sales per Employee VYNT's Asset Turnover Ratio
VYNT's Net Margin VYNT's Pb Price to Book ratio VYNT's Financial Strength Ratios VYNT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2022 Inventories at quarter ending Dec 31 2022
Dariohealth Corp   2.26 $ 18.001  Millions$ 8  Millions
Immucell Corporation  2.25 $ 10.919  Millions$ 5  Millions
Conformis inc   2.24 $ 38.837  Millions$ 17  Millions
Qiagen N v   2.23 $ 696.472  Millions$ 312  Millions
Boston Scientific Corporation  2.22 $ 3,956.000  Millions$ 1,786  Millions
Glaukos Corp  2.21 $ 68.979  Millions$ 31  Millions
Lexaria Bioscience Corp   2.20 $ 0.082  Millions$ 0  Millions
Rxsight Inc   2.20 $ 27.677  Millions$ 13  Millions
Apollo Endosurgery inc   2.19 $ 34.429  Millions$ 16  Millions
Tenon Medical Inc   2.17 $ 1.332  Millions$ 1  Millions
Sanara Medtech Inc   2.16 $ 6.361  Millions$ 3  Millions
Valion Bio Inc   2.12 $ 1.541  Millions$ 1  Millions
Lifeloc Technologies Inc   2.11 $ 5.407  Millions$ 3  Millions
Inotiv Inc   2.10 $ 141.917  Millions$ 68  Millions
Acutus Medical Inc   2.10 $ 31.910  Millions$ 15  Millions
Lensar Inc   2.09 $ 15.532  Millions$ 7  Millions
Acorda Therapeutics Inc   2.09 $ 30.332  Millions$ 15  Millions
Quotient Limited  2.09 $ 37.131  Millions$ 18  Millions
Avanos Medical Inc   2.08 $ 370.000  Millions$ 178  Millions
Medtronic Plc  2.08 $ 10,331.000  Millions$ 4,964  Millions
Cutera Inc   2.08 $ 112.570  Millions$ 54  Millions
Coherus Oncology inc   2.07 $ 70.083  Millions$ 34  Millions
Biolase Inc   2.05 $ 32.551  Millions$ 16  Millions
Silk Road Medical Inc   2.02 $ 37.876  Millions$ 19  Millions
Inmode Ltd   2.01 $ 73.485  Millions$ 36  Millions
Pacira Biosciences inc   2.01 $ 199.295  Millions$ 99  Millions
Elite Pharmaceuticals Inc   2.01 $ 15.257  Millions$ 8  Millions
Hologic Inc  2.00 $ 1,205.100  Millions$ 602  Millions
Journey Medical Corp  2.00 $ 30.775  Millions$ 15  Millions
Fortress Biotech Inc   2.00 $ 30.775  Millions$ 15  Millions

Date modified: 2026-06-22T16:30:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.